Don't miss the term platform...
The receipt of the $10 million will provide additional funding to further the development of Clarity’s TCT platform of products for various cancer indications.
TCT - Targeted Copper TheranosticsThe Company is a leader in innovative radiopharmaceuticals, developing Targeted Copper Theranostics based on its SAR Technology Platform for the treatment of cancer in children and adults.
Don't miss the term platform...The receipt of the $10 million...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.42 |
Change
0.350(6.90%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $5.10 | $5.53 | $5.10 | $8.270M | 1.560M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1951 | $5.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.44 | 4280 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |